From China to the world, Professor Zhang Luo's inspiration journey in chronic nasal diseases

doi:10.3969/j.issn.1006-7795.2020.05.004

Abstract

Abstract: Professor Zhang Luo entered the Capital Medical College (current Capital Medical University) in 1988. He received his Bachelor's degree in medicine in 1993 and his Doctorate in 2000. As the Changjiang Distinguished Professor and the winner of the National Science Fund for Distinguished Young Scholars, he devoted himself in the field of chronic nasal diseases and achieved numerous innovative results in epidemiology, pathogenesis, clinical diagnosis and treatment. Professor Zhang is one of the pioneers in the field of rhinology in China.

Key words: Changjiang Scholar, chronic nasal disease, precision medicine

CLC Number:

R765

Zhao Zhiyue, Zhang Luo. From China to the world, Professor Zhang Luo's inspiration journey in chronic nasal diseases[J]. Journal of Capital Medical University, 2020, 41(5): 742-747.

0
/ / Recommend

Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks

URL: https://journal03.magtech.org.cn/Jweb_sdykdxxb/EN/10.3969/j.issn.1006-7795.2020.05.004

https://journal03.magtech.org.cn/Jweb_sdykdxxb/EN/Y2020/V41/I5/742

References

[1] Cheng L, Chen J, Fu Q, et al. Chinese society of allergy guidelines for diagnosis and treatment of allergic rhinitis[J]. Allergy Asthma Immunol Res, 2018, 10(4):300-353.
[2] Bao Y, Chen J, Cheng L, et al. Chinese guideline on allergen immunotherapy for allergic rhinitis[J]. J Thorac Dis, 2017, 9(11):4607-4650.
[3] Li H, Chen S, Cheng L, et al. Chinese guidelines on sublingual immunotherapy for allergic rhinitis and asthma[J]. J Thorac Dis,2019, 11(12):4936-4950.
[4] Liu Z, Chen J, Cheng L, et al. Chinese Society of Allergy and Chinese Society of Otorhinolaryngology-Head and Neck Surgery guideline for chronic rhinosinusitis[J]. Allergy Asthma Immunol Res, 2020, 12(2):176-237.
[5] Zhang L, Han D, Huang D, et al. Prevalence of self-reported allergic rhinitis in eleven major cities in China[J]. Int Arch Allergy Imm,2009, 149(1):47-57.
[6] Wang X, Zheng M, Lou H, et al. An increased prevalence of self-reported allergic rhinitis in major Chinese cities from 2005 to 2011[J]. Allergy, 2016, 71(8):1170-1180.
[7] Zheng M, Wang X, Bo M, et al. Prevalence of allergic rhinitis among adults in urban and rural areas of China-a population-based cross-sectional survey[J]. Allergy Asthma Immunol Res, 2015, 7(2):148-157.
[8] Lou H, Ma S, Zhao Y, et al. Sensitization patterns and minimum screening panels for aeroallergens in self-reported allergic rhinitis in China[J]. Sci Rep, 2017, 7(1):2986.
[9] Meng Y, Lou H, Wang Y, et al. Endotypes of chronic rhinitis:a cluster analysis study[J]. Allergy, 2019, 74(4):720-730.
[10] Wang X, Zhang N, Bo M, et al. Diversity of T-helper cytokine-profiles in chronic rhinosinusitis:A multicenter study in Europe, Asia and Oceania[J]. J Allergy Clin Immunol, 2016, 138(5):1344-1353.
[11] Lou H, Meng Y, Piao Y, et al. Cellular phenotyping of chronic rhinosinusitis with nasal polyps[J]. Rhinology, 2016, 54(2):150-159.
[12] Lou H, Meng Y, Piao Y,et al. Predictive significance of tissue eosinophilia for nasal polyp recurrence in the Chinese population[J]. Am J Rhinol Allergy, 2015, 29(5):350-356.
[13] Lan F, Zhong H, Zhang N,et al. IFN-λ1 enhances Staphylococcus aureus clearance in healthy nasal mucosa, not in nasal polyps[J]. J Allergy Clin Immunol, 2019, 143(4):1416-1425.
[14] Yan B, Lou H, Wang Y, et al. Epithelium-derived Cystatin-SN enhances eosinophil activation and infiltration via interleukin-5 in chrbonic rhinosinusitis with nasal polyps[J]. J Allergy Clin Immunol, 2019, 144(2):455-469.
[15] Zhang L, Wang C, Han D, et al. Comparative study of cluster and conventional immunotherapy schedules with dermatophagoides pteronyssinus in the treatment of persistent allergic rhinitis[J]. Int Arch Allergy Imm,2008, 148(2):161-169.
[16] Huang Y, Wang C, Cao F, et al. Comparison of long-term efficacy of subcutaneous immunotherapy in paediatric and adult allergic rhinitis patients[J]. Allergy Asthma Immunol Res, 2019, 11(1):68-78.
[17] Lou H, Huang Y, Ouyang Y, et al. Artemisia annua sublingual immunotherapy for seasonal allergic rhinitis:a randomized controlled trial[J]. Allergy, 2020, 75(8):2022-2032.
[18] Wang C, Lou H, Wang X,et al. Effect of budesonide transnasal nebulization in eosinophilic chronic rhinosinusitis with nasal polyps[J]. J Allergy Clin Immunol, 2015, 135(4):922-929.
[19] Lou H, Wang C, Zhang L. Steroid transnasal nebulization in the treatment of chronic rhinosinusitis[J]. Curr Opin Allergy Clin Immunol, 2016, 16(1):39-44.
[20] Zhang Y, Lou H, Wang Y,et al. Comparison of corticosteroids by three approaches in the treatment of chronic rhinosinusitis with nasal polyps[J]. Allergy Asthma Immunol Res,2019, 11(4):482-497.
[21] Han D, Chen L, Cheng L, et al. A multicenter randomized double-blind 2-week comparison study of azelastine nasal spray 0.1% versus levocabastine nasal spray 0.05% in patients with moderate-to-severe allergic rhinitis[J]. ORL J Otorhinolaryngol Relat Spec, 2011, 73(5):260-265.
[22] Zhang L, Zhang Y, Gao Y, et al. Long-term outcomes of different endoscopic sinus surgery in recurrent chronic rhinosinusitis with nasal polyps and asthma[J]. Rhinology, 2020, 58(2):126-135.
[23] Zhang L, Sanderson M J. The role of cGMP in the regulation of rabbit airway ciliary beat frequency[J]. J Physiol, 2003, 551(3):765-776.
[24] Qing H, Wang X, Zhang N,et al. The effect of fine particular matter on the inflammatory responses in human upper airway mucosa[J]. Am J Respir Crit Care Med, 2019, 200(10):1315-1318.
[25] Ouyang Y, Li J, Zhang D, et al. A model to predict the incidence of allergic rhinitis based on meteorological factors[J]. Sci Rep, 2017, 7(1):10006.